Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up

CONCLUSIONS: Our data did not allow us to find significant differences in pregnancy outcome and infant follow-up, as well as in placental histological picture in preeclamptic patients when pravastatin is administered in the late second trimester. However, we suggest its possible role in stabilizing the disease, increasing the prenatal weight gain and prolonging the duration of pregnancy, thus preventing the progression to a more severe maternal disease.PMID:36764034 | DOI:10.1016/j.ejogrb.2023.01.036

Source: Reproductive Biology - February 10, 2023 Category: Reproduction Medicine Authors: Stefano Fruci Silvia Salvi Sascia Moresi Francesca Gallini Marco Dell'Aquila Vincenzo Arena Enrico Di Stasio Sergio Ferrazzani Sara De Carolis Antonio Lanzone Source Type: research